Anhui Sunhere Pharmaceutical Excipients Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001ZH5
CNY
15.82
-0.46 (-2.83%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
223.25
222.97
247.87
238.22
194.43
212.24
237.69
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
223.25
222.97
247.87
238.22
194.43
212.24
237.69
Raw Material Cost
155.83
153.86
170.51
175.54
141.40
141.66
159.13
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.37
3.25
3.16
2.69
3.44
3.31
3.30
Selling and Distribution Expenses
17.46
12.95
12.63
14.77
13.03
13.95
13.40
Other Expenses
0.65
0.58
0.85
0.95
0.34
0.69
0.85
Total Expenditure (Excl Depreciation)
183.10
175.88
194.83
202.52
161.23
165.77
184.31
Operating Profit (PBDIT) excl Other Income
40.099999999999994
47.1
53
35.699999999999996
33.199999999999996
46.5
53.4
Other Income
9.10
8.23
6.48
7.65
15.70
7.28
7.05
Operating Profit (PBDIT)
49.25
66.09
70.22
14.97
60.03
64.10
70.30
Interest
3.37
3.25
3.16
2.69
3.44
3.31
3.30
Exceptional Items
-1.13
2.89
-0.53
3.38
-12.81
3.62
2.67
Gross Profit (PBDT)
67.42
69.11
77.36
62.68
53.03
70.58
78.56
Depreciation
0.00
13.33
13.33
13.16
13.16
12.42
12.42
Profit Before Tax
44.75
52.41
53.21
2.49
30.62
51.99
57.25
Tax
5.45
5.83
6.55
5.41
3.48
6.22
6.73
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
39.53
45.86
47.18
-3.00
26.89
45.72
49.82
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
39.53
45.86
47.18
-3.00
26.89
45.72
49.82
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.23
0.72
-0.52
0.09
0.25
0.06
0.70
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
39.30
46.58
46.66
-2.91
27.14
45.78
50.52
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
962.86
923.50
952.51
869.67
909.43
847.35
893.57
Earnings per share (EPS)
0.17
0.19
0.19
-0.01
0.12
0.19
0.21
Diluted Earnings per share
0.17
0.19
0.19
-0.01
0.12
0.19
0.21
Operating Profit Margin (Excl OI)
17.98%
19.97%
20.34%
-2.45%
16.03%
20.92%
21.38%
Gross Profit Margin
20.04%
29.48%
26.84%
6.57%
22.52%
30.35%
29.31%
PAT Margin
17.71%
20.57%
19.03%
-1.26%
13.83%
21.54%
20.96%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2025 is 0.13% vs -10.04% in Jun 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is -15.67% vs -0.21% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is -30.74% vs -9.11% in Jun 2025

stock-summary

Interest

QoQ Growth in quarter ended Sep 2025 is 6.25% vs 0.00% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

Compare Quarterly Results Of Anhui Sunhere Pharmaceutical Excipients Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
223.25
0
223.25
Other Operating Income
0.00
0.00
0.00
Total Operating income
223.25
0
223.25
Raw Material Cost
155.83
0
155.83
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
3.37
0
3.37
Selling and Distribution Expenses
17.46
0
17.46
Other Expenses
0.65
0.00
0.65
Total Expenditure (Excl Depreciation)
183.10
0
183.10
Operating Profit (PBDIT) excl Other Income
40.15
0.00
40.15
Other Income
9.10
0
9.10
Operating Profit (PBDIT)
49.25
0
49.25
Interest
3.37
0
3.37
Exceptional Items
-1.13
0
-1.13
Gross Profit (PBDT)
67.42
0
67.42
Depreciation
0.00
0
0.00
Profit Before Tax
44.75
0
44.75
Tax
5.45
0
5.45
Provisions and contingencies
0
0
0.00
Profit After Tax
39.53
0
39.53
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
39.53
0
39.53
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.23
0
-0.23
Other related items
0.00
0.00
0.00
Consolidated Net Profit
39.30
0
39.30
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
962.86
0
962.86
Earnings per share (EPS)
0.17
0
0.17
Diluted Earnings per share
0.17
0
0.17
Operating Profit Margin (Excl OI)
17.98%
0%
0.00
17.98%
Gross Profit Margin
20.04%
0%
0.00
20.04%
PAT Margin
17.71%
0%
0.00
17.71%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 22.33 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 0.13% vs -10.04% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 14.87% vs 4.80% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 3.93 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -15.67% vs -0.21% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 45.02% vs -22.13% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.01 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -30.74% vs -9.11% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -9.48% vs 2.07% in Sep 2024

Quarterly - Interest
Interest 0.34 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 6.25% vs 0.00% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 0.00% vs 142.86% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.98%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024